Shares of Forty Seven Inc (NASDAQ:FTSV) have earned a consensus recommendation of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $27.71.

FTSV has been the subject of a number of recent research reports. HC Wainwright reiterated a “buy” rating and set a $21.00 price objective on shares of Forty Seven in a research note on Monday, January 14th. Zacks Investment Research cut Forty Seven from a “hold” rating to a “sell” rating in a research note on Wednesday, February 6th. ValuEngine lowered Forty Seven from a “buy” rating to a “hold” rating in a report on Monday, December 17th. BTIG Research started coverage on Forty Seven in a research report on Friday, December 21st. They set a “buy” rating and a $36.00 price objective on the stock. Finally, Oppenheimer set a $35.00 price objective on Forty Seven and gave the company a “buy” rating in a report on Friday, January 11th.

In related news, Director Irving Weissman sold 9,664 shares of the stock in a transaction that occurred on Monday, February 4th. The shares were sold at an average price of $15.02, for a total value of $145,153.28. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Chris H. Takimoto sold 8,000 shares of the stock in a transaction that occurred on Friday, January 4th. The shares were sold at an average price of $15.55, for a total transaction of $124,400.00. The disclosure for this sale can be found here. Insiders sold 115,363 shares of company stock valued at $1,767,688 over the last quarter.

Several institutional investors and hedge funds have recently made changes to their positions in FTSV. Citadel Advisors LLC lifted its position in shares of Forty Seven by 144.4% in the 3rd quarter. Citadel Advisors LLC now owns 572,923 shares of the company’s stock worth $8,548,000 after purchasing an additional 338,489 shares during the period. JPMorgan Chase & Co. boosted its position in Forty Seven by 51.2% during the third quarter. JPMorgan Chase & Co. now owns 346,066 shares of the company’s stock worth $5,164,000 after purchasing an additional 117,142 shares during the period. Millennium Management LLC purchased a new stake in shares of Forty Seven in the second quarter worth about $1,940,000. BlackRock Inc. purchased a new stake in Forty Seven in the second quarter valued at approximately $548,000. Finally, United Services Automobile Association purchased a new stake in Forty Seven in the second quarter valued at approximately $994,000. 42.96% of the stock is owned by institutional investors.

NASDAQ FTSV opened at $14.58 on Friday. Forty Seven has a 1 year low of $12.02 and a 1 year high of $23.83.

Forty Seven (NASDAQ:FTSV) last issued its earnings results on Tuesday, November 13th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.54) by ($0.17). Analysts expect that Forty Seven will post -3.42 EPS for the current fiscal year.

Forty Seven Company Profile

Forty Seven Inc, a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; and FSI-189, an antibody that binds to SIRPa for the treatment of solid tumors.

Further Reading: How to find the components of the quick ratio

Analyst Recommendations for Forty Seven (NASDAQ:FTSV)

Receive News & Ratings for Forty Seven Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forty Seven and related companies with MarketBeat.com's FREE daily email newsletter.